Business

Marijuana edibles company Dixie Elixirs settles one dispute, still embroiled in another

Dixie Elixirs, a Denver-based marijuana edibles company, recently announced that it has settled a dispute with a California company with which it previously partnered to produce Dixie Botanicals, a line of hemp oil products that includes tinctures and balms. Under the terms of the settlement, the California company, Medical Marijuana...
Carbonatix Pre-Player Loader

Audio By Carbonatix

Dixie Elixirs, a Denver-based marijuana edibles company, recently announced that it has settled a dispute with a California company with which it previously partnered to produce Dixie Botanicals, a line of hemp oil products that includes tinctures and balms.

Under the terms of the settlement, the California company, Medical Marijuana Inc., will take over the hemp-derived Dixie Botanicals (after a ninety-day transition period), leaving Dixie to “develop and expand” its lines of THC-infused products.

“From a consumer perspective, there won’t be a difference,” says Dixie spokesman Joe Hodas. “This is more a question of two companies dissolving a partnership.”

Dixie, however, is still embroiled in a dispute involving the inventor of MED-a-Mints, a popular THC mint candy. The inventor, Gary Gabrel, claims that Dixie violated the contract between them when it changed the MED-a-Mints packaging, making its own name more prominent and removing the words “cannabis infused.”

Will you step up to support Westword this year?

At Westword, we’re small and scrappy — and we make the most of every dollar from our supporters. Right now, we’re $20,000 away from reaching our December 31 goal of $50,000. If you’ve ever learned something new, stayed informed, or felt more connected because of Westword, now’s the time to give back.

$50,000

For more on Dixie Elixirs, read our feature story on managing director Tripp Keber.

Follow me on Twitter @MelanieAsmar or e-mail me at melanie.asmar@westword.com

GET MORE COVERAGE LIKE THIS

Sign up for the This Week’s Top Stories newsletter to get the latest stories delivered to your inbox

Loading latest posts...